Doses to head and neck normal tissues for early stage Hodgkin lymphoma after involved node radiotherapy

Radiotherapy and Oncology

Volumn 110, Issue 3, 2014, Pages 441-447

  Maraldo, M V ^a   Brodin, N P ^a   Aznar, M C ^a,b   Vogelius, I R ^a   Munck Af Rosenschold P ^a,b   Petersen, P M ^a,c   Specht, L ^a,c  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

3DCRT; Hodgkin lymphoma; Normal tissues; Proton therapy; Radiotherapy; VMAT

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; PREDNISOLONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CERVICAL LYMPH NODE; CLASSICAL HODGKIN LYMPHOMA; CLINICAL ARTICLE; COMPARATIVE EFFECTIVENESS; COMPUTER ASSISTED RADIOTHERAPY; EARLY CANCER; FEMALE; HUMAN; HUMAN TISSUE; INTENSITY MODULATED PROTON THERAPY; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; INVOLVED NODE RADIOTHERAPY; LARYNX; LYMPH NODE METASTASIS; MALE; MANTLE FIELD RADIOTHERAPY; MULTIMODALITY CANCER THERAPY; NECK MUSCLE; ORGANS AT RISK; PAROTID GLAND; PHARYNX; PRIORITY JOURNAL; PROTON THERAPY; RADIATION DOSE; RADIATION RESPONSE; RADIOTHERAPY PLANNING SYSTEM; SUBMANDIBULAR GLAND; THREE DIMENSIONAL CONFORMAL RADIOTHERAPY; THYROID GLAND; VOLUMETRIC MODULATED ARC THERAPY; ADVERSE EFFECTS; CANCER STAGING; HEAD; HODGKIN DISEASE; LYMPH NODE; MIDDLE AGED; NECK; PATHOLOGY;

ADULT; FEMALE; HEAD; HODGKIN DISEASE; HUMANS; LYMPH NODES; MALE; MIDDLE AGED; NECK; NEOPLASM STAGING; ORGANS AT RISK; PROTON THERAPY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 84899528143     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2013.09.027     Document Type: Article

References (21)

1. H.T. Eich, V. Diehl, and H. Gorgen et al. Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD11 trial J Clin Oncol 28 2010 4199 4206
2. A. Engert, A. Plutschow, and H.T. Eich et al. Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma N Engl J Med 363 2010 640 652
3. A. Engert, P. Schiller, and A. Josting et al. Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's Lymphoma Study Group J Clin Oncol 21 2003 3601 3608
4. T. Girinsky, R. van der Maazen, and L. Specht et al. Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: concepts and guidelines Radiother Oncol 79 2006 270 277
5. B.S. Chera, C. Rodriguez, and C.G. Morris et al. Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy Int J Radiat Oncol Biol Phys 75 2009 1173 1180
6. C. Fiandra, A.R. Filippi, and P. Catuzzo et al. Different IMRT solutions vs. 3D-Conformal Radiotherapy in early stage Hodgkin's lymphoma: dosimetric comparison and clinical considerations Radiat Oncol 7 2012 186
7. J. Koeck, Y. Abo-Madyan, and F. Lohr et al. Radiotherapy for early mediastinal Hodgkin lymphoma according to the German Hodgkin Study Group (GHSG): the roles of intensity-modulated radiotherapy and involved-node radiotherapy Int J Radiat Oncol Biol Phys 83 2012 268 276
8. N.N. Lu, Y.X. Li, and R.Y. Wu et al. Dosimetric and clinical outcomes of involved-field intensity-modulated radiotherapy after chemotherapy for early-stage Hodgkin's lymphoma with mediastinal involvement Int J Radiat Oncol Biol Phys 84 2012 210 216
9. M.V. Maraldo, N.P. Brodin, and M.C. Aznar et al. Estimated risk of cardiovascular disease and secondary cancers with modern highly conformal radiotherapy for early-stage mediastinal Hodgkin lymphoma Ann Oncol 24 2013 2113 2118
10. D.C. Weber, N. Peguret, and G. Dipasquale et al. Involved-node and involved-field volumetric modulated arc vs. fixed beam intensity-modulated radiotherapy for female patients with early-stage supra-diaphragmatic Hodgkin lymphoma: a comparative planning study Int J Radiat Oncol Biol Phys 75 2009 1578 1586
11. M.V. Maraldo, M.C. Aznar, and I.R. Vogelius et al. Involved node radiation therapy: an effective alternative in early-stage Hodgkin lymphoma Int J Radiat Oncol Biol Phys 85 2013 1057 1065
12. M.V. Maraldo, N.P. Brodin, and I.R. Vogelius et al. Risk of developing cardiovascular disease after involved node radiotherapy versus mantle field for Hodgkin lymphoma Int J Radiat Oncol Biol Phys 83 2012 1232 1237
13. Special considerations regarding absorbed-dose and dose-volume prescribing and reporting in IMRT J ICRU 10 2010 27 40
14. C.M. Nutting, J.P. Morden, and K.J. Harrington et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial Lancet Oncol 12 2011 127 136
15. W. Bethge, D. Guggenberger, and M. Bamberg et al. Thyroid toxicity of treatment for Hodgkin's disease Ann Hematol 79 2000 114 118
16. L.S. Constine, S.S. Donaldson, and I.R. McDougall et al. Thyroid dysfunction after radiotherapy in children with Hodgkin's disease Cancer 53 1984 878 883
17. S.L. Hancock, R.S. Cox, and I.R. McDougall Thyroid diseases after treatment of Hodgkin's disease N Engl J Med 325 1991 599 605
18. J.A. Bucher, T.J. Fleming, and L.M. Fuller et al. Preliminary observations on the effect of mantle field radiotherapy on salivary flow rates in patients with Hodgkin's disease J Dent Res 67 1988 518 521
19. N.A. Rodrigues, L. Killion, and G. Hickey et al. A prospective study of salivary gland function in lymphoma patients receiving head and neck irradiation Int J Radiat Oncol Biol Phys 75 2009 1079 1083
20. E.M. van Leeuwen-Segarceanu, L.D. Dorresteijn, and S. Pillen et al. Progressive muscle atrophy and weakness after treatment by mantle field radiotherapy in Hodgkin lymphoma survivors Int J Radiat Oncol Biol Phys 82 2012 612 618
21. A. Paumier, M. Ghalibafian, and A. Beaudre et al. Involved-node radiotherapy and modern radiation treatment techniques in patients with Hodgkin lymphoma Int J Radiat Oncol Biol Phys 80 2011 199 205